Frances Hoffman

Frances Hoffman, MSN, APRN-CNP

Board Member

Frances Hoffman joined the MHIF Board of Directors in 2023 after retiring from Allina Health – Abbott Northwestern Hospital where she served as Administrative Director of the Advanced Heart Failure and Transplant Programs. During a career that spanned over 30 years, she was privileged to work closely with physicians and staff of MHIF on multiple clinical studies involving state-of-the-art technology for the treatment of heart failure. She has also held leadership positions in several professional associations, including participating on national committees, serving in elected office and on boards of directors of NATCO – the organization of Transplant Professionals, the United Network for Organ Sharing, and the International Society for Heart and Lung Transplantation.

Frances’ passion for improving the quality of health care through education and research fuels her strong commitment and enthusiastic support for the mission and work of the Minneapolis Heart Institute Foundation.

Frances earned a Bachelor’s Degree in Nursing from the College of St. Scholastica and completed her Masters of Science in Nursing and Acute Care Nurse Practitioner programs at the University of Minnesota. 

Back to Board of Directors

Frances Hoffman
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.